Development of a Novel Risk Score to Select the Optimal Candidate for Cytoreductive Nephrectomy Among Patients with Metastatic Renal Cell Carcinoma. Results from a Multi-institutional Registry (REMARCC)

Risk Score ◽

Renal Cell ◽

Cytoreductive Nephrectomy ◽

Optimal Candidate

Corrigendum to ‘Development of a Novel Risk Score to Select the Optimal Candidate for Cytoreductive Nephrectomy Among Patients with Metastatic Renal Cell Carcinoma. Results from a Multi-institutional Registry (REMARCC)’ [European Urology Oncology 3 (2021) 256–263]

European Urology Oncology ◽

10.1016/j.euo.2021.04.007 ◽

2021 ◽

Author(s):

Michele Marchioni ◽

Maximilian Kriegmair ◽

Mathias Heck ◽

Thomas Amiel ◽

Francesco Porpiglia ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Risk Score ◽

Renal Cell ◽

Cytoreductive Nephrectomy ◽

Optimal Candidate

1255: Potential Role of Postoperative Azotemia in Predicting Response to Interleukin-2 (IL-2) Immunotherapy Following Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma

The Journal of Urology ◽

10.1016/s0022-5347(18)31469-1 ◽

2007 ◽

Vol 177 (4S) ◽

pp. 414-414

Author(s):

John S. Lam ◽

Rakhee H. Gael ◽

Tobias Klatte ◽

Fairooz F. Kabbinavar ◽

Arie S. Belldegrun ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Renal Cell ◽

Potential Role ◽

Interleukin 2 ◽

Faculty Opinions recommendation of Does timing of cytoreductive nephrectomy impact patient survival with metastatic renal cell carcinoma in the tyrosine kinase inhibitor era? A multi-institutional study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717979900.793471988 ◽

2013 ◽

Author(s):

Hendrik van Poppel ◽

Yuri Tolkach

Keyword(s):

Renal Cell Carcinoma ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Cell Carcinoma ◽

Renal Cell ◽

Kinase Inhibitor ◽

Patient Survival ◽

Faculty Opinions recommendation of The value of cytoreductive nephrectomy for metastatic renal cell carcinoma in the era of targeted therapy.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.9841956.10548054 ◽

2011 ◽

Author(s):

Axel Bex

Keyword(s):

Renal Cell Carcinoma ◽

Targeted Therapy ◽

Cell Carcinoma ◽

Renal Cell ◽

Editorial Comment to Expression of tertiary lymphoid structure in deferred cytoreductive nephrectomy of metastatic renal cell carcinoma treated with nivolumab plus ipilimumab

IJU Case Reports ◽

10.1002/iju5.12360 ◽

2021 ◽

Author(s):

Takeshi Yuasa

Keyword(s):

Renal Cell Carcinoma ◽

Editorial Comment ◽

Cell Carcinoma ◽

Renal Cell ◽

External validation of a predictive model of survival after cytoreductive nephrectomy for metastatic renal cell carcinoma

World Journal of Urology ◽

10.1007/s00345-018-2427-z ◽

2018 ◽

Vol 36 (12) ◽

pp. 1973-1980 ◽

Cited By ~ 2

Author(s):

Lorenzo Marconi ◽

Roderick de Bruijn ◽

Erik van Werkhoven ◽

Christian Beisland ◽

Kate Fife ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Predictive Model ◽

Renal Cell ◽

External Validation ◽

Sunitinib Alone or After Nephrectomy for Patients with Metastatic Renal Cell Carcinoma: Is There Still a Role for Cytoreductive Nephrectomy?

European Urology ◽

10.1016/j.eururo.2021.06.009 ◽

2021 ◽

Author(s):

Arnaud Méjean ◽

Alain Ravaud ◽

Simon Thezenas ◽

Christine Chevreau ◽

Karim Bensalah ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Renal Cell ◽

1796 AN ASSESSMENT OF LYMPHADENECTOMY OMISSION AT CYTOREDUCTIVE NEPHRECTOMY FOR METASTATIC RENAL CELL CARCINOMA: A POPULATION-BASED ANALYSIS

The Journal of Urology ◽

10.1016/j.juro.2012.02.1827 ◽

2012 ◽

Vol 187 (4S) ◽

Author(s):

Marco Bianchi ◽

Maxine Sun ◽

Quoc-Dien Trinh ◽

Jens Hansen ◽

Zhe Tian ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Renal Cell ◽

Population Based ◽

Association between cytoreductive nephrectomy and survival among patients with metastatic renal cell carcinoma receiving modern therapies: a systematic review and meta-analysis examining effect modification according to systemic therapy approach

Cancer Causes & Control ◽

10.1007/s10552-021-01435-z ◽

2021 ◽

Author(s):

Mary E. Hall ◽

Bimal Bhindi ◽

Amy N. Luckenbaugh ◽

Aaron A. Laviana ◽

Kelvin A. Moses ◽

...

Keyword(s):

Systematic Review ◽

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Systemic Therapy ◽

Renal Cell ◽

Meta Analysis ◽

Effect Modification ◽

Cytoreductive Nephrectomy ◽

Therapy Approach

686 THE RATE OF TRANSFUSIONS, COMPLICATIONS, LENGTH OF STAY, AND IN-HOSPITAL MORTALITY IN PATIENTS TREATED WITH CYTOREDUCTIVE NEPHRECTOMY FOR METASTATIC RENAL CELL CARCINOMA PATIENTS

The Journal of Urology ◽

10.1016/j.juro.2011.02.1653 ◽

2011 ◽

Vol 185 (4S) ◽

Author(s):

Maxine Sun ◽

Firas Abdollah ◽

Claudio Jeldres ◽

Jan Schmitges ◽

Daniel Liberman ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Length Of Stay ◽

Hospital Mortality ◽

Cell Carcinoma ◽

Renal Cell ◽